Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 demonstrated the momentum we built as a business,” commented ...

Bionano Genomics BNGO just pulled back the curtain on its fourth-quarter results, and the message is clear: the company is ...

Transformational automation accelerates time to results by up to 93.6% for cytogenetics laboratories worldwide ...

THIS is a preliminary report of an investigation in progress dealing with cytogenetics of orthopteran insects of the southern hemisphere belonging to the family Acrididae and new to cytology. In this ...

A real-world analysis of patients receiving teclistamab prior to 2022 showed comparable outcomes to clinical trials and ...

Bionano Genomics (NASDAQ: BNGO) participated in the 2026 American College of Medical Genetics and Genomics Annual Meeting (ACMG), held March 14–18 in Baltimore, Maryland. Twelve studies, representing ...

Get the latest Metropolis Healthcare share price today on NSE & BSE. Explore Metropolis Healthcare stock analysis, financial performance, market capitalization, dividend history, and future outlook ...

(NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...

PhD, FACMG has been elected President of the ACMG Foundation for Genetic and Genomic Medicine. The ACMG Foundation works to advance American College of Medical Genetics and Genomics (ACMG) educational ...

During a live event, Marc J. Braunstein, MD, PhD, and participants discussed maintenance lenalidomide and daratumumab as well as the clinical potential of MRD in multiple myeloma.

Each chromosome pair viewed in a karyotype appears to have its own distinct "bar code" of bands. What changes do scientists look for in a karyotype when diagnosing diseases and disorders? The process ...

Cincinnati Children's Applied Gene and Cell Therapy Center selected to conduct tech transfer, development and IND-enabling manufacturingAll activities other than long-term stability testing planned to ...